0000721371-24-000012.txt : 20240228 0000721371-24-000012.hdr.sgml : 20240228 20240228162054 ACCESSION NUMBER: 0000721371-24-000012 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240228 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CARDINAL HEALTH INC CENTRAL INDEX KEY: 0000721371 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 310958666 STATE OF INCORPORATION: OH FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11373 FILM NUMBER: 24695731 BUSINESS ADDRESS: STREET 1: 7000 CARDINAL PLACE CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147573033 MAIL ADDRESS: STREET 1: 7000 CARDINAL PLACE CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: CARDINAL DISTRIBUTION INC DATE OF NAME CHANGE: 19920703 8-K 1 cah-20240228.htm 8-K cah-20240228
0000721371false00007213712024-02-282024-02-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 28, 2024
 
Cardinal Health, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Ohio 1-11373 31-0958666
(State or Other Jurisdiction
of Incorporation)		 (Commission
File Number)		 (IRS Employer
Identification No.)
7000 Cardinal Place, Dublin, Ohio 43017
(Address of Principal Executive Offices) (Zip Code)
(614) 757-5000
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common shares (without par value)CAHNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨




Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 28, 2024, the Board of Directors (the “Board”) of Cardinal Health, Inc. (the “Company”) elected Robert W. Azelby to the Board, effective March 1, 2024, to serve until the 2024 annual meeting of shareholders and until his successor is elected and qualified or until his earlier resignation, removal from office, or death. The Board has appointed Mr. Azelby to serve on the Board's Risk Oversight Committee. Mr. Azelby is the former President and Chief Executive Officer of Eliem Therpeutics, Inc., a biotechnology company focused on developing therapies for neuronal excitability disorders.

The Board has affirmatively determined that Mr. Azelby is “independent” under the rules of the New York Stock Exchange and the rules and regulations under the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act").

Mr. Azelby will receive compensation consistent with that received by the Company’s other non-employee directors, as described in the Company’s proxy statement on Schedule 14A for the 2023 annual meeting of shareholders, filed with the U.S. Securities and Exchange Commission on September 27, 2023.

There are no arrangements or understandings between Mr. Azelby and any other person pursuant to which he was appointed as a director. At this time, there are no transactions in which Mr. Azelby has or will have an interest that would be required to be disclosed pursuant to Item 404(a) of Regulation S-K under the Exchange Act.

Item 7.01.    Regulation FD Disclosure.

The Company issued a news release on February 28, 2024 announcing the election of Mr. Azelby to the Board, which is being furnished as Exhibit 99.1 to this Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
2

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  Cardinal Health, Inc.
(Registrant)
Date: February 28, 2024  By: /s/ Jessica L. Mayer
   Name: Jessica L. Mayer
   Title: Chief Legal and Compliance Officer

3
 EX-99.1 2 exhibit991-feb2024newbodme.htm EX-99.1 Document
Exhibit 99.1

image_0.jpg


Bob Azelby to join Cardinal Health Board of Directors

DUBLIN, Ohio, February 28, 2024 – Cardinal Health (NYSE: CAH) announced today that its Board of Directors has elected Robert “Bob” Azelby as an independent director, effective March 1. Mr. Azelby joins the board with over 30 years of experience, including as a Chief Executive Officer and board member for large, matrixed organizations in the biopharmaceutical, oncology and other specialty industries.
Mr. Azelby has previously served as President and Chief Executive Officer of Eliem Therapeutics, and prior to Eliem, he was the Chief Executive Officer of Alder BioPharmaceuticals. Before joining Alder BioPharmaceuticals, Mr. Azelby was the Chief Commercial Officer of Juno Therapeutics, and served 15 years in a variety of commercial roles at Amgen.
Mr. Azelby currently serves on the Boards of Directors of ADC Therapeutics and Autolus Therapeutics. He also formerly served on the Boards of Directors for Chinook Therapeutics, Eliem Therapeutics, Clovis Oncology, Immunomedics, Alder BioPharmaceuticals, and Cascadian Therapeutics.
“Bob Azelby is a highly respected healthcare industry leader with a strong track record of leading large, complex organizations as both a CEO and a board member,” said Greg Kenny, Chairman of the Board for Cardinal Health. “Bob’s vast experience and expertise within the specialty pharmaceutical arena will add great value to our company and we’re pleased to welcome him to our board.”
“Bob brings to our board more than three decades of experience and high performance across a multitude of healthcare industries, including oncology and other specialty areas, which I believe will make him a uniquely valuable addition,” said Jason Hollar, CEO of Cardinal Health. “We look forward to tapping into Bob’s extensive expertise as we continue the momentum against our strategic priorities.”
Mr. Azelby holds a BA in Economics and Religious Studies from the University of Virginia and an MBA from Harvard Business School.
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With more than 50 years in business, operations in more than 30 countries and approximately 48,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.



Contacts
Media: Erich Timmerman, erich.timmerman@cardinalhealth.com and 614.757.8231
Investors: Matt Sims, matt.sims@cardinalhealth.com and 614.553.3661



 EX-101.SCH 3 cah-20240228.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 cah-20240228_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 5 cah-20240228_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image_0.jpg begin 644 image_0.jpg MB5!.1PT*&@H -24A$4@ N, #T" ( "^4[_Y 7-21T( KLX< MZ0 1G04U! "QCPO\804 )<$A9

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htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover Page
Feb. 28, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Feb. 28, 2024
Entity Registrant Name Cardinal Health, Inc.
Entity Incorporation, State or Country Code OH
Entity File Number 1-11373
Entity Tax Identification Number 31-0958666
Entity Address, Address Line One 7000 Cardinal Place
Entity Address, City or Town Dublin
Entity Address, State or Province OH
Entity Address, Postal Zip Code 43017
City Area Code 614
Local Phone Number 757-5000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common shares (without par value)
Trading Symbol CAH
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0000721371
Amendment Flag false

EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( )J"7%@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " ":@EQ8/&HO*.X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M3L,P#(9?!>7>NLT H:C+!<0))"0F@;A%CK=%:]HH,6KW]K1AZX3@ 3C&_O/Y ML^0&@\(^TDOL T5VE*Y&WW9)85B+/7-0 GWY$TJIT0W-;=]](:G9]Q!,'@P M.P)95;?@B8TU;& &%F$A"MU85!C)(L+/GS&-L,L K7DJ>,$=5F#T//$ M5+.3=1M9*5NI&?LRN/_PNPKZW;NO^ ML?%94#?PZR[T%U!+ P04 " ":@EQ8F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M )J"7%@;6:*K. 0 '00 8 >&PO=V]R:W-H965T&UL ME9AO;]LV$,:_"J$!0PLDD2C_368;<)QD"=HF1IRMV(:]H"7:(BJ1&DG%\;?? M478D;Y5/[IM(E'2/?^0='Y(9;93^9A+.+7G+4FG&7F)M?N7[)DIXQLR%RKF$ M-RNE,V:AJ=>^R35G<1F4I7X8!'T_8T)ZDU'Y;*XG(U785$@^U\046<;T]IJG M:C/VJ/?^X%FL$^L>^)-1SM9\P>UO^5Q#RZ]48I%Q:8221//5V)O2J^NPZP+* M+WX7?&,.[HGKRE*I;Z[Q$(^]P!'QE$?623"XO/(93U.G!!S_[$6]ZC==X.'] MN_I=V7GHS)(9/E/I5Q';9.P-/1+S%2M2^ZPV]WS?H9[3BU1JRK]DL_NVV_5( M5!BKLGTP$&1"[J[L;3\0!P&=8P'A/B LN7<_5%+>,,LF(ZTV1+NO05A=7P5D"[V+#([%W?'E!PN$9"8.P M^]]P'S JEK!B"4N]#LKRUW1IK(9L_=U$M%/H-BNX$KXR.8OXV(,:-5R_/X)@>A6$-W3(.9<"Q636QD3 MR'PC#ZY4I:\M?[T*K8<*WDHK[)8\\[5P&03&1Y8U@N$Z,Z9C(5E*[CE+;7)& M'F1T@?#U*[[^*7R@IG2N-'.V<$86%D:/*$UFJI!6;^$:-T+CXD_W".&@(AR< M0G@G4DX>BVS)=1,(KD'/*>T,.@C-L*(9GD+SPM[(0PPE)U8B*@<-8<,5._0\ MN.P-^_T^@G=9X5V>@C>-8YCJYNS]AGR&[\B3;,PAKC@(@H!4U3=/P4@03AK4 M'AO\$.G,M:#B7M1&-MHN+G=3+.$11G;@_O2'R*K),-?J5 M#"CNX9]5Y"HU41(SC!:106]PWH/2QXCJ-8#BYOU5"VNYA(')LD+N#<,T4N%" M*Y8:=/K5MD]Q:UZH5$3""KDF7Z"\M6!I(P^NTLI3FSS%'7JN^7D$P\-A?NWV M$US&L/-Y6JV.Y _7:R6K#9_B_OP=V8,Q!9"U N*RK8"UY5/65KPC]B&MG;^$+?J M%\UB5W>+;;94C577(C";8FX:UD8?XJ;\/E+D]BU*F%SSHWNS%J''/Q:W&-'! M9O\D?[_-N%Z[(?H5%&SB?"-GLC&C+8)M51;6]A[B[KQ'F\$,T&"O#U#\;^03 M;X;"I7.#H(/D'9TAW'O_"7%H, M2?D*A(*+ ;BUWAUQ=PVK\O)8N506#JGE;<(9V(3[ -ZOE++O#7=2K?[1,/D7 M4$L#!!0 ( )J"7%B?H!OPL0( .(, - >&PO9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8Q MYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_* M%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2 M,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T] M.PP_/LG>V)+;.'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D M'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3 M\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_R MBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P M6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8 MLAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z M'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8 M"<:1/,<0F,7XC&894IT,/O'^8* \^ M>Q\ETWLJ.?]74_P$4$L#!!0 ( )J"7%B7BKL

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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.cardinal.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports cah-20240228.htm cah-20240228.xsd cah-20240228_lab.xml cah-20240228_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "cah-20240228.htm": { "nsprefix": "cah", "nsuri": "http://www.cardinal.com/20240228", "dts": { "inline": { "local": [ "cah-20240228.htm" ] }, "schema": { "local": [ "cah-20240228.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "cah-20240228_lab.xml" ] }, "presentationLink": { "local": [ "cah-20240228_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.cardinal.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cah-20240228.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "cah-20240228.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.cardinal.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0000721371-24-000012-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000721371-24-000012-xbrl.zip M4$L#!!0 ( )J"7%A69V08S! !1Y 0 8V%H+3(P,C0P,C(X+FAT M;>T];5/C.-+?]U>HLG4W4(4=VW'("Y K-F1F%?C5^.^PJ:0=-8UB,>?S\I])4:UHO%N[L[>]05D9V(FZ+G M.*4B?NY2R0I9V#X[AERZE:)71S[>]*.9YN\<^O7SI!GPVH MQ6.I:!Q,,!XM4"CKY]9JM:+^FC5=W0CIG8\7LBD4&N(<<_B M"I-)H:/_(&E MF0.T'E%8X@*+K6^=0N.XSVC8.!XP10GVM]A?*;\]*3236+%86=?C(70+S--) M0;&1*FH8BXU??OGE6'$5L49 ^Q; XSN>5STNFG?'13-R-PG'C>.0WQ*IQA$[ M*81<#B,ZKL=)S&!^/JIC0R;,KSP,6:Q_A>_GZ8 )'ICI1^J*]4X*@06+&M,! MCL1XO17#=.,F "=HU(Y#-OK,Q@7"PY-"S_+<0L.!?Q7/+57H*B'Y2 MD'PPC'#-]+N^T(#-4-H>R1"604\WG2.;4B:IT$^:-^H9 MXG./,T$T2&RIW#7;G^?)>K]S(W\U/_H0J).$^1-PI%!G5+$&XH-2C[QS_]L$ MS'!%T_Q+_IQ/4IS#.R?2A"K%&;8K G,:#D7J\'+ :DZUU/5]O^?W>CYE0=?Q M:+?LAB5:8>'_(_6F?3*N'O#8ZC-^TU=UW[,KY:$ZNN.AZM==Q_E'03=M',LA M!9;H"EPT\[L99W$T*FY@0)4,ZR48"5&P:,1OXGH -&6B8,;*FP=)E(CZKX[^ M=]0#G*T>'?!H7/]P*CB-R#D5(KG[<"!!38(^%;QG6DG^7U9W?9A"/]X9!"HP M"&K$'"'70Q2^G;>O6V>DK,PS\#^4Z VFDUOUVUK]NM#CD]/R.M/YN_ MGYY_:I'FQ=>O[4ZG?7&^V_#_<=KYO7W^Z?KB_("<-8GGE/W:2HAG>,5_@%>6 M\=WR4+J*UE?2Y\E08I*VI@LHZ1!5JO6Y_L:FOPL,;=$!N<> M&?RE9/CGK^ZA<[0C*[<> X/X7;7.K\E5Z_+BZOJEA,U;"];+5,B4QHJHA'18 M@ ZDH;A;(HD@;GDOW"=)CZ@^VVU$ /A4<,7!SVB-@CZX&8R.Y%(B)6\#S&*EZ"&^L 0S1QVY62,?6&'"V6#QQ.T$OLJY(J1@3KWI MT"5:]$"W3HOUENU=L3X69&\]Q;II8'3%;KC$Z%B=PY>C//PV20]+=SK*QNHF2B4#S>VW3"@> MT"BC@B:(^3R-:VS'Q#8*@B@5YC-GGVWX5%Q\7W+M0[^Z])-CNQN]]^QRI;)1 MCU5 >36[XF\VU/, 57YX\J*FO,@_YMR3L4,(ZB%"YCDIE IYFR$-,<57=X@+ MK8J[W2S#[T?MO>$(>RQ*[0(7)\-GUE/.8Y0VJ.)$@&.CDYD=!2Y!,TEC)<;- M))SW%S WBMD2Q88BN<5QIHZ"7VA<]'FRRCCP\7 M%*2S1$$^"J%7S2@?><2@<1?L4[;HY4+#M5RW5"F]K_O;7?=K.FIGV=9 *XEY M)C@L-$JNY=3*U(+ M_,,YM;K_+@\[O9[-9##@4N;+AYJ.&"Y_7[G=7KGV58>T!L,H&3.AUVY>59'S MQ-Y?5$)%'8B\>'9JVRD?HZ]/PU P*;,?7V \-]?5E4(#YG#()!Z_C&BPL*5X ML$$:?&[*)OQZ(:Z3NXE;6"TTSM(NX+2U.;3JO1"7X(%RO^QNPSI<$=.5E M/XGO.="N!P)9KEAEP/Z5\6SF21+&(#1%)$FLL#PCP4I2B*2$4 MB H46I-U7FU6[-D!;/99\!UWBP@=@M(;PL#@F7:3$>FR*+DC7&\ED8^@)$G5 M^DQZ/,+EX!+61K$X9"'N1$D^2"-%8Y:D,AH3";93]L:Z9]8A 25^8TRJV9TB M8IH 36$<06@\SK_UD@@FQWZHB#DZ5I+L/>6FB1ZNSD$G\V -LDG&GF$+9_G< MY!.+F8#!VC'0+]51 SFU/=LLV7Y]5Y.PM9I=+9^=A[-)!L&Z7\(KD"2,81)X\SME8MN43=)HBX%L52@ M'";VIX0JKE;Q_:.GS^ \>;IC.24S^@ "LP0BPYF-^*L4I,CWRIDB0PTVL[V- MN]I[;H4T/UX1K^38T'"=D.)=.M^ED]<["1@DX*/XYBL89@1B7='TW[YH3HE# M!AEU%N72]2GXR3.B.5=N,A%,'YA,MWQDN/]N4-]%UHCLI6!H3+&^61?XH9[^>H)LVKZ;V7>9?93,MJ5,F7B$ MY!Z^2^ZBY):8Y>\%ZTENUO;Q1GAIWN?91=QWRX^H-:I5-ZLU6CF49WM5;UM# M^:7EGQY4%[7'_,G=VEU#+Z\UU(F30989I0L H4//W]G4;SC)9[0*;0_;YSB;(ZO_WLUD"< MV1WY3R*^DXY*@N\3)^K'-5.[$/14G,JF'E'-LTO.9@7-JX8JVWZMMKD7<_C* M?/-V'*(?SDAW3 *]LP>+]1W4/=-U9O>VW;@D !\X\;B>-^0&IE=]=.>'N!5' M)0E9#Z;09Q),BMLIYU[/O?RV.;55(GNXX5DYTFGNO#%, XPZQ!,-6/)F8@*O M:WE+QEIV%&PR*,8'TWXSP]ID_KCHSUDQ@03=D05M+5^4))8H;)4X_*%&H<^Z%,6 M00 )^C1.=#B92J9; ?)9)05>#,-UB&ENAD"FUG-%8YP<74]=)A&#)P!?!+OE M$OJ!EJ9Q@!C3(,##%]@8+U$)J0BEJ:$(5\6RI3TZB65GU:]--CVE^@=,B\LJ M?X[BJ.VKBS4S#UQ(\9"CLZK3C#C?NPECF)@UJ L642Q@6[@;8RKI6FB=:1?: ME4F4JL4N/[I.8]-K/2J3:SWZ8BI5-\SJ"D:_6[0'=K%.HSLZEBB/3W;W!ZI: M"QA8T$#593H [A\?9>)MH2S7_4E2#F0%_/:ZY3]YK=/RFK.V8@-2MAW/-F59 MB_\_8Q#5J53HJ/F,"Y"11$@4M29H) I^D*EE%/*(M*),@F:;'I'3X3#AL=*9 M4?BRV \-%HLEA>9CMYAU@,]69D& 9,2&(U/S00V^0O&, >#X=NTO;E9 "V ! .I M,^\'\#!(;F'*GD@&,!]RT %V"QE5?9M<3\B)MH@:/H6!OXI9E TNP-83W#]( MQSUELH"19(E18@ M,D#@Q)#!QT":-3L@E'1YHAA$PL""-^-)8-)+@A2M'L 8LEL6)4.D+P8X=(@Q M!-K,F*4B03: 2)J#4> 1.(X$'##MFTG[!\6QB^+P"H3HWOH"A?4- $2@=&,]("W!AMEEA?U$WOIJEFB'_'8\BH%+ 4"R"W#:@78% M2&)^%D1(.WYZX;*6(?J;2),9;:9KJ!,=Z$-88S%SJH4!UV>:\\#$]#(0O&NB M^F4C@+*5*;G2#Y3< 5;_PDP9^(OKCAPR6=3I M(2H])X/0'JO B5?1JK:TVA:^:ID%9P,H!DL&/V:= 6'D1;OQZ%23+E-WC,6S MLHOTTV73>M4A9I 8.LQX^2;1#Y2_FU/Y^##A"QA-F7R*X@.FS>X4)AV2T, ( M,,]W#F9 0%T#L&HV[M-;U &Z-%S@O3>:9>^2- )^Q6CHKY0+4S'>1;Z4093( M>W&)=M)\Q\^BDJN)_B =Z_.*+>1':H)==E,KMN.N=%-GB/+Q##PC34?P6A\P M:V_*7;R>JBTP7S)%CL:8&#=N(T:E]E\6'$I45A 9'^D]ZJM?X!$0U.3KB7."6B 5AM+6>REWA/UIQF MR"3Z>?.95=>N>!O7RU1LO[I9/G/U^\/:P^G,]>_3<1&1+>18JV :@\/]39V M.%!Y;K"=L=V[>[:6?^[UGH8^!K*0!=E%$'7M &$K (@N3<(QHWF.7A8Z8FZ MSH"IU5RKQ[IHA<%,=Y-PP.R^&N@M[:G1SDSY?&2SU)0?%^G*'/"KEPC7\5^' M0#P[99K)+6:6*'C];0PQJ$G(G5%%B;YS8P\CQC#,0LXLP&UK\T3PQGP29I=: M;E)?^AS; P^FTW?B)+.W>M?B97<@=N**@$[[T_GI];>K!^X:7W:S019'>;ZF MPDLLZ^Q]PF;'4L?HDPV)->HS3*+^:GZK,TRC,0FH3M3JN,AN%ZN&GJC9=H^]O=R:X3WM M]64QT[9K!G=6T/ZV&N858O3;N/Z6T'E["U241?)O)B4 0[[8Y"O%FQ(?46G] MMQ7!=\27-\N",0S5H!V12<1#DN/P]JCR-M#%\TIULH,*X852DB^L#=ZQWF6L M,W0(_O1*=GD)9G-5&)YG+\LRO0RV^APLB+HIW?S";O!X 99RXG$$CG^@-:_B M7.O X1JE)>^)=H2RM#K17C1_GE;_2=O&_P!02P,$% @ FH)<6,9V0G5P M @ >@< ! !C86@M,C R-# R,C@N>'-DS55=3]LP%'WOK_#R/.>K+6LC M6J2!D"9U&V*@\38Y]DUBD=J9[=#R[['=1"5 -RKM87VI<^\YYW[Y)J=GVW6- M'D!I+L4B2,(X0""H9%R4B^#VYA+/@K/E:'3Z >.[S]"KFIB"JG6&"\][5PVCXJ7E4%IG$YZ6.]563YA+*=I@I/I M#/"D*!*=*LS32M8$V1+$SK;ZD50&=-D4;39;,+-.)2JC-(X3J*[KZL?'AITV)J+ M^P%ZFZNZQX\CY\Z)AAY.235 4Z)LXT@=4KF.7+5QFLX"1(Q1/&\-7-JV7$!! MVMHL@E;\;DG-"P[,]KP&U]4!X)G;$%6"^4;6H!M"X1U!ER.$7"OXNI'*(/$F MM>M%,I_/HZTK+D"[UJTD)<;?B(.]\'CLCCA)\3@)MYH%T;O"#H6XT(8("L?$ MMD^XY_V+'/:#/2Z'GG=\#EY, PU+^1 QX&YRX[?#ZT-P=\#N,(Q)A)#&\YVE MLS4-%X7<&:S))9[UV5]#T>_*JP5XXXKXOXPHJF3]E_L4-4HVH P'_7QYO$"E MH%@$=H5P?VE_-0I"FTB/>*4_G(!SVP"@[>+XGH)\]A8"6W'4,.N0_]Q M^37)CRW?4J ^LFY'O+%^Q-DB.)?VY7]%2IN7L]]>?SG\M==E4'#! M_;V+_2]!>/^]P,@SD:.>1B\)+Z1:#>R[6/KSRPEWY [R!R(E-6WKXWG[M [2 M.F/?R6[/HN&B[9Z?+:,W[#9\.7H"4$L#!!0 ( )J"7%BBD\3M<0H $M> M 4 8V%H+3(P,C0P,C(X7VQA8BYX;6S57%UOVS@6?>^OT'I?=H%A34J4 M1!9M!MU,NR@VTP9-BAGL8F'P,Q%J2X&L-,F_7TJV$RN6;%**5>U+XMA7E^>> MZ%S>2])Z^^O]8N[]4/DRR=)W$_0:3CR5BDPFZ=6[R;?+CX!,?CUY]>KM7P#X M\Q]?S[S?,G&[4&GAG>:*%4IZ=TEQ[177ROLCR[\G/YAW/F>%SO(% "?59:?9 MS4.>7%T7G@]]O#';?)J_X5A*+GP$4$@4P%HCP ,F 48R8LQ'.L3REZLW6")) M_4@ KD+S810HP"!4@',B8RQ\GX:\3977Y7VRM_?OGYJ'9).2XMIJJ[*_^VYRI-,7A0L+\X85W.#OO)6 M/-RH=Y-ELKB9J\U[U[G2S6[G>5[S6J*D)4H4E2C_VC;8M ?\%\);[&)] 7!5 MN)]?"N,^3C^_&-Q+DR'4\0%O#=,;\NJ&^I#*H>[=QZ%Z0S\^XI>Z+;*"S0>X M+9Z&V8(\+]\X,Z_6PY2.]B33:IQUZMZ"JNX+E4JURI8UUUXBWTW,JYE4R>Q" MB=L\*1X^W(MKEEZISVRA9C"4D>*: Z:$ #C$!- H,A-3H#%F!(:01;/B\9Z> MJ11\N]@,7XVQ?X")0V1%BT)SM7V4_IN92$[\?E"] ^:)24ZO#Z=\CGETDQ5S,.$0FA$2Y"IMS$ M!&E 8A\#I7V%. T1CI&K<#?.QR;:"I27:0_Y?^-_]S9PW57[R)Z]8KMP1A-$MVQ<9?G'\:/F81/L\7B-DU67=%R!F$,"=%FMO MG 2[-_9.JFWV.)AT]P:TK=_]ANXB+I:4Z*(J>GC0&" M9<@ 94P#RIEB6 GFA];%\7/G8Y-NA<^K 'HKA/:RW2'NL&+[T'%DL3HPX234 MMI [:73'V6#R; MC6YFM-NZBO,Q9N9)[\;#@V7RF<:QQ0&(@5< IDH#'H4< M^%RA2$/)0V*MR)KGLKB3ZG(\ILLKR;6BX(5ZC2[38O\X323:A:$F"@F.(A$ M8!I0'$! ?12 *#"3(XPH%Y#82M%BO+$)= 79JV'^Q:M0&YJ]-7*OA&ZO7AO> M#VOZA=D\LM)?@DBG-.! 3Z?D8.-_L)3A$.QV(G&YK&MZ>2^EN8^6E=\O^7F> M_4A,.#/J8R%P% (D. %8,0YH*"+ XE#[,(A5&$.WO-(\T$@3RAKLE@(V@%W3 M2 N_MOFC/VO#)(X.A'5(%_O9Z)$G6AP/G"#VA[>;&0[8NZ>$\UR5?;PR7LJS M&9^6RUN57Y;;6OD7K4U+"1%F(54,$"AC@$WU 8@((5 ""4TH0WX0VJ:%0X.- M+348O$!L ?96B+T59*_";)\=#E)].$.\)(%'SA*]N'-*%+:D=$H6!YT/EC!L MP]Q.&M;7N">.S6FNQP,,OYF4-"-13$Q;0H!F$3=%1!@!0C4&VI>8(R< 9V:<1+\W^DY*;_8XF+SW M!K2MZ?V&[D(^S7ZH_#U?%CD3Q8P$@DD)(8A$1,N%/C/Q4RE ()G&1MW8Y];; MVS7/8Q-N!<[[SP;>?^T%6R?LL% [TW!D@5HSX"3,QF@[";+N:3 A-@:P+%RJ^2].J?>7977)O9^H:E#S.?$C.!*@XB20* F4* \R &,@YC$OJ8 M,-]:AGO&&9LHUZWE!JNW NNMT;HVXLW4VO;AO0D;I@UWY:I##[Z7B1XM>+/? M@3OPO<'M-N#[S7OWW]OMH)":QF8N+E?V&< R"@%'1 11%Q',L TL-YS:Q]F M;"E@IV]\D6:[5YO]?])@'[VS/E)//89NVJV/?ID.^B*;)R(I3#+YW53P><+F M,PAQ$ AP.UK:&G6WPZ6[[H8[7MH:2NV :;M5A_ZX7';/%:LV@0G$U*;SD>FS1/JQT> \YQ([U&ED5KW)&"8W?& M=M&[]<4-H79KB[<=#=<5-\"O-<5-G_?F ,< M(P8HE!HP% >(,Q@8]77:GZX-,S8A/M]L78'U#-I.1UP:F;7MB/OR-4Q#[$Q5 M]UWI1B;Z[TG7W?Z<'>G&T%KWHYNMNV\J79I+9R+4.H!&\(I #3")?,"4'YBY M5JN(*D(U#%SWDDK'8Y/XXT9)".T*5 MH\$W@K;A-^W_U#YWE]I[XT.6?C[.V=7,EUA27GZ+6I"HU!HKM28!D@$AF&NM M(;;56LWSV,3V",XKT=FKK4[78;EU)N'(>K.,WTEPC;%V4ES=TV"2:PQ@6W/- M!EW+VU/C*&?S3ZE4]_]2#S,B)8>,:T @Q0!S) !GB@"N:8@A]WT.K8]8-8XP M-A&N*[4U2J^"Z1F] Q3P]HSTZ%X;8F^1]WZW./ )6M+0+O5 M:IMA5R%_3.:;;]XA26-&& >!KR# OHH 98(")L-8* B1,HV6DX:?G(]4OB5 MYZ\L[A!GJ]EN= PC5QLF.@AU-^0>&MUR-K \=\/856:#3<_%HW)!ZDM^F=VE M,X[B( QU () ^>4WIC#@G%$@_$#[<2"@H:O3RM'3&".5Z.-:2+6BF>5>B;7C MFM$6H8X+1MUH&GBUR(JA[DM%NQST7R?:\OES%HEV@VI=(6HP[2KP2W;_29J9 M/-'K9P^L9Q(H HV(F7V#&-)RRU0 QB !%,6:2C^*8_NG!NP=::1B-VB].MR. MLW,;P;:R?P':AA&_.V,=$L !-GJD@3;/ R># P'NIH1#%_2<^=>_SI)4H1F& M<>C[(@!"4@8P-"4YB25;/'C]Y]3]0 M2P,$% @ FH)<6(GQ+1JM!@ Z3 !0 !C86@M,C R-# R,CA?<')E M+GAM;-6:6V_;QA+'W_TI=-37,];>N!9B6B%&FL MZ-C^]F=)VTT<.RUA"C#SH@NUY,S\YZ?=V2'?_'BSJ6:?,&W+ICZ_,O@-__\^%L]E/CKS98M[.3A+;%,+LNV_6L7>/L MMR;]67ZRL_/*MK%)&X"C_K23YO(VE:MU.V.$B8=A#[^F R="<)Y1H(5&$#%2 M<-P&$#1(:QF-A0C_7AV(0(-ATH/#(O\H.8(E!,$Y'93PC)G"]1>MROK/@^[% MV2W.7!8G%]?;U_XU*UWZ35@A'"%P^CY_?#;YZ,O^;]:&J, M6?2__C5T6SXW,%^6+G[_^>RC7^/&0EEO6UO[SL"V/-CV!\\:;]M>]7_T:_;- M$=TW>!@&W2&@##C=O]F&^='>;'8G1VHJ_(!QUKW_^N'TD4EO4\ZVK?9]LUET M Q8G30;BW*XZ=_O3V]M+/)QOR\UE]=>Q=<)X./=V#5U:"6.ZL_G#YW,7G\U? M)MQF9OIPS_*!^TMTQE[F"MZT6 >\"_'!2M7X1X.J3N F/9Q968=5?W09L%SV M5SYVVS99WRXYM39P&D 91T%80L$(&8$K*1SQ3&MM'T?>N;W-?O?YV*+?7S6? M%OG".2^,=Q\Z77BOR1-S=]J\S.^'/^!%'KN,EDJC101K9/[O2%N EMX!52@B MB3P08D:Y_:6UQUY_F=/CY&=-"ICR#/)@SB;_)+^/V;T?L;BT*5\(_+JLPL/9 M,36;7>2J;7:@W%U:LKOS68XZ8DH8SNZR\LW@^LC:/*]B/W(7&3_'5#;A;1U^ MRA/ODLA("L,]:(PQ!\ LY-,L<,8\%919QW GJ7]D=A #;/H,O%S+5X;A;=V6 M[>T'7)6=$G7[B]W@4GBTWD>;U? RJ\$\&$\-4&J#8-R*X,:Q\)S502CPZ:(P M6LE)D'":B[5TV:1>^(]9?SQIKNHVW9XT 9W?>HSM=-_;!]DL)D4+6%8$S(!1 3V7=G@7E'?>%-$0P;E?:O+0Y+_82[ MF*,D?.7T_Y;*ML7ZI-ELKNK[+=)V&;E CLZ -YB58#D*IYT'R2E';8*S2$8Q M\*S982!,N(NX+3.?B8*QH0A;+@4+JL MA9+*4XM,\U$H/+4YC(,)]RA'ROC*$)PG[ C&7-CV]^>Z6[OI?G+6)#Q$'S7 M.A%YQRRB86"TT1"E8UXZ&="/NW7_3QX, V7"C2Z*"RGXQZ1^-KB,!PFW*H<)>$KI_\BV>[1 MM8^W&]=42Q+SEHB9;B/<%4(&\S1'K 07E":*1F.<'Y7[1^:&)7["[1 M/_W;&[^V]0K[6_E<4J>C1XC=K3GA;02C5"Z%.2,,HQS6EG[,ZC($)=QU' M2SF);N/;#:951OF_J;ENUWEQN[3U[=*Y:%WD1>:8Q;R,9:*M*"P8Z9037%!% MQO67_L;XL >G)M]O'"_L)/@XR9(E6YWF$N?F?Y@#B,8)% %01)Y7.(J@!2OR MCEDQH:G#X,<5"<^:'<;$A%N0X\5\91J.<[T;NIKW76572R>EECI/<]E[FZ#O+^IO%$_'.\H&CO?L?NI?NR?BC MO?\#4$L#!!0 ( )J"7%@L 8+K!@< " 9 > 97AH:6)I=#DY,2UF M96(R,#(T;F5W8F]D;64N:'1MU5EK<]NX%?W>7W%K3[/MC"3K:2F2US.VXC;> MUIN=S6XS_;0#DE>>>RX 760N M5Y<7&8OD\@\7?VRWZ96.JYP+1[%AX3BARLHBI7<)VWMJMYM>)7)),OCV1_<&HWQ\.DFX\ M.!^.NOQR,AP.QDF_.QXDD_%H_$OO!$/1O1YCW5KQMR>Y+-H9^_6GXW[I9BN9 MN&S:ZW;_=++7S_&#:PLETV(:K$7K0L.WICG62IOI:3=\9KZEO1"Y5.OI-U=& M"O5-RXK"MBT;N:B;K7S/TUX/2X;'56W#$*.5+'AC4VW(S4,F(^GHYD+6Q(=O:F\V@$S*AUDN3 J, M(NVLXK6Y#3]JF5!;T9/&?9UUS^DS9^__]?; MFQ>GH\F,YE>O_T*B*(!)#%EU.A&@6R8<26>?X!=EPA(K/'!2N_6CCI#$Y+WK M=V<@;?@&/VONUITP2!0DBX1+QC\XGC0SMH@7"WR32ZZ[W@D39]3KT)WI;/CO MR6]A%E,4+%I)>*$A'C3HTIH%[(*1_% "'X8C+2P5JRKQ-<(O3?-,\H)N'CBN M_$KT9K&0,8:+(FFFS#F''[30AA1(CRERX8Q\ "C:I**0[X63&E8@#8,A4I>9 M,+F(N0H2UB)=^#"FZS"K1B=#MN08X7-K[WME,2';#GUVNGU=FNP [J-<&EY* M75FU)DRX!!!X^8-A*T, O9/'8$4P;I3DG'X""*(,"-E6&%(:"8@A:*%#BP#E M2M2Q_,T+&@2$^VL5\8@M)N (ZEJK@<9 ML/LZX(/R:KZ'4 #HJG):57:OH0/AP9[!:I]>@&?+J \LX#,1 2JTOC^(PU/4 MFBN]E);>-"G8HML\1P1S3D+S<5H$&@L;BT1"H?:M?J81VTKM)G#2:UR&+D 6 M"5H&>49J>;6/!=*C49\U*6QW@4004 %SC4;2.(.ZB(&QKM7>=_+)U @A.%TJ M?CC00>00_/>SS&_>!!C%GI2V-G7 "IG0WPRG]'DQ"E,#=^OS! MJHEA KU7F<2>X)8B1NHON8Y=+NYK^ 55A?QWQ2"_CZ*(%/O 2L_3?19^)RP4 MY[568'8K\!86'B/=.R;EQ0<.KCPTP,F)LO0VRP(/NZ3$08$+ZXO6EHI(D!6# M2H63A:<6*)EK?_BL8'(JL*-Q 7A @B-M*N.Z-L)L[!$V9N/S?#?GCQ@6SBV[ MVPBM$L^(ZRM?*&^ A)'Q#+U^PMZ"Z[ 9UH8G0>8?BZ I+&R+JG_E-Y- M*6J-*>@.LX6NKX59^L!<^\L !O7>QIG6JG/D6/O[G-JN(EVY0T[MGK$^)4+] MH?_[XA$Z/ ^$\I%(GYL1RG?8_Y2/"B6E2D?"YUU1+43L*M-LH ]&AIKK919- M2D0:[-:H/*71216[IN0*_[R42;W9VI,1/Z-P*$[81]2EQI>&'1W!XE+5:4+O M?"';BM:HN]V710TML#''_-O=^[8W#@\QP ^25%M5PJH'B9T_Q.1Y'"!#P&@X M:6%>8A1BO6986\="H9H^;UX!?RB>WPY#,7WT.G1;A%C[>)!X*EL"'Y="JEK) MG1\7VFL.=%!W'^?XX7V3OX KM0U%8&I8"7^D.'HEUVAH=SM$1(%_QX=\PH7* M[O_,;"8H10>A$_4URHWQ&Y2?I#_\0<9:Q/Y%QVU>O#@]'\X>TSB(SGEOV!F/QIU) M?]![II[>%C@-^E-9[>V=<([>RMR&2Q+7L?CZ6QZ.1H/.X/S\\9WS%[Z@/'II M^^%YGKMLG-6_4)R%7T;^ U!+ 0(4 Q0 ( )J"7%A69V08S! !1Y 0 M " 0 !C86@M,C R-# R,C@N:'1M4$L! A0#% @ MFH)<6,9V0G5P @ >@< ! ( !^A &-A:"TR,#(T,#(R M."YX XML 17 cah-20240228_htm.xml IDEA: XBRL DOCUMENT 0000721371 2024-02-28 2024-02-28 0000721371 false 8-K 2024-02-28 Cardinal Health, Inc. OH 1-11373 31-0958666 7000 Cardinal Place Dublin OH 43017 614 757-5000 false false false false Common shares (without par value) CAH NYSE false